78 related articles for article (PubMed ID: 565235)
1. A comparison of apomorphine, bromocriptine and Sandoz CM 29-712 (6-methyl-8a-cyanomethyl-ergoline-l) in four different turning models in the rat [proceedings].
Jaton AL; Loew DM; Vigouret JM
Br J Pharmacol; 1978 Mar; 62(3):395P. PubMed ID: 565235
[No Abstract] [Full Text] [Related]
2. Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.
Johnson AM; Loew DM; Vigouret JM
Br J Pharmacol; 1976 Jan; 56(1):59-68. PubMed ID: 943193
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of three dopamine agonists: apomorphine, bromocriptine and lergotrile.
Silbergeld EK; Pfeiffer RF
J Neurochem; 1977 Jun; 28(6):1323-6. PubMed ID: 577501
[No Abstract] [Full Text] [Related]
4. Stereotyped responses of rats to two 2-halogenoergolines: 2-bromo-alpha-ergocryptine and lergotrile.
Bergmann F
Isr J Med Sci; 1982 Jan; 18(1):177-82. PubMed ID: 6121772
[TBL] [Abstract][Full Text] [Related]
5. The effect of L-dopa and lergotrile mesylate on the interaction of fluphenazine decanoate and amphetamine-induced stereotypy and mortality.
Lemberger L; Kellams JJ; Small JG; Rowe H
Commun Psychopharmacol; 1977; 1(5):501-7. PubMed ID: 564259
[No Abstract] [Full Text] [Related]
6. Proceedings: The effects of buprenorphine, morphine and pentazocine on turning behaviour and stereotypy induced by apomorphine in the rat.
Cowan A; Dettmar PW; Walter DS
J Pharm Pharmacol; 1975 Dec; 27 Suppl?-2():15P. PubMed ID: 2687
[No Abstract] [Full Text] [Related]
7. Neuropharmacological investigations with two ergot alkaloids, Hydergine and bromocriptine.
Loew DM; Jaton AL; Vigouret JM
Postgrad Med J; 1976; 52suppl 1():40-46. PubMed ID: 822407
[No Abstract] [Full Text] [Related]
8. Inhibition of apomorphine-, bromocriptine- and lergotrile-induced circling behaviour in rats by subsequent haloperidol administration.
Heal DJ; Green AR; Buylaert WA
Neuropharmacology; 1980 Jan; 19(1):133-7. PubMed ID: 6102352
[No Abstract] [Full Text] [Related]
9. Methodone interaction with apomorphine- and amphetamine-induced turning.
Stratten WP
Res Commun Chem Pathol Pharmacol; 1975 Aug; 11(4):675-8. PubMed ID: 1237160
[No Abstract] [Full Text] [Related]
10. The effect of unilateral carotid occlusion on apomorphine-induced turning in rats.
Mears A; Barnett A
Arch Int Pharmacodyn Ther; 1974 Sep; 211(1):128-32. PubMed ID: 4477705
[No Abstract] [Full Text] [Related]
11. A novel, fully automated rotometer for the study of turning behavior. Comparison of results under different experimental conditions.
D'Anna L; Loidl CF; Pecci-Saavedra J; González SA; Soqueff MN; Campastro OJ; Fernández RA
Acta Physiol Pharmacol Latinoam; 1989; 39(3):255-68. PubMed ID: 2576765
[TBL] [Abstract][Full Text] [Related]
12. Evidence for metabolite involvement in bromocryptine-induced circling behaviour [proceedings].
Jenner P; Marsden CD; Reavill C
Br J Pharmacol; 1979 May; 66(1):103P-104P. PubMed ID: 572254
[No Abstract] [Full Text] [Related]
13. Dopamine agonist activities of pergolide, its metabolites, and bromocriptine as measured by prolactin inhibition, compulsive turning, and stereotypic behavior.
Clemens JA; Okimura T; Smalstig EB
Arzneimittelforschung; 1993 Mar; 43(3):281-6. PubMed ID: 8489554
[TBL] [Abstract][Full Text] [Related]
14. Pre- and postsynaptic action of bromocriptine: its pharmacological effects on shcizophrenia and neurological diseases.
Trabucchi M; Andreoli VM; Frattola L; Spano PF
Adv Biochem Psychopharmacol; 1977; 16():661-5. PubMed ID: 196497
[No Abstract] [Full Text] [Related]
15. Apomorphine and piribedil in rats: biochemical and pharmacologic studies.
Butterworth RF; Poignant JC; Barbeau A
Adv Neurol; 1975; 9():307-26. PubMed ID: 1170716
[TBL] [Abstract][Full Text] [Related]
16. The effects of cholinergic agonists on apomorphine-induced stereotyped behavior in the rat.
Sahakian BJ; Growdon JH; Millington WR; Barr JK; Wurtman RJ
Commun Psychopharmacol; 1978; 2(3):255-62. PubMed ID: 568059
[No Abstract] [Full Text] [Related]
17. Neurochemical and behavioral correlates of chronic apomorphine administration in the rat.
Kenny M; Leonard BE
Adv Biochem Psychopharmacol; 1978; 19():347-9. PubMed ID: 567934
[No Abstract] [Full Text] [Related]
18. Bromocriptine-induced behavioral hypersensitivity: implications for the therapy of parkinsonism.
Nausieda PA; Weiner WJ; Kanapa DJ; Klawans HL
Neurology; 1978 Nov; 28(11):1183-8. PubMed ID: 568738
[TBL] [Abstract][Full Text] [Related]
19. Proceedings: CF 25-397 (9, 10-didehydro-6-methyl-8beta-(2-pyridylthiomethyl) ergoline), a new central dopamine receptor agonist.
Jaton AL; Loew DM; Vigouret JM
Br J Pharmacol; 1976 Mar; 56(3):371P. PubMed ID: 944059
[No Abstract] [Full Text] [Related]
20. Differential actions of typical and atypical neuroleptic agents on two behavioural effects of apomorphine in the mouse [proceedings].
Costall B; Naylor RJ; Nohria V
Br J Pharmacol; 1978 Jun; 63(2):381P-382P. PubMed ID: 27276
[No Abstract] [Full Text] [Related]
[Next] [New Search]
